Arjun Chandran is an associate in the Antitrust & Competition group in the London office of Kirkland & Ellis International LLP. His practice focuses on advising clients on antitrust matters relating to mergers & acquisitions, joint ventures and other business combinations. His practice also includes general antitrust advisory work, competition law compliance, and cartel investigations.
Experience
Representative Matters
Since joining Kirkland, Arjun’s representative matters have included advising:
Trinseo on the €1.137 billion contemplated acquisition of Arkema’s PMMA business
GlaxoSmithKline plc on its transaction with Pfizer Inc. to combine their consumer healthcare businesses in a new world-leading joint venture, with combined sales of approximately $12.7 billion
A consortium consisting of EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority on the CHF 10.200 billion acquisition of Nestlé Skin Health, a leading global skincare company
Hospital Topco (majority owned by Centerbridge and KKR) on the UK merger control aspects of the c.£1.8 billion disposal of BMI Healthcare and the GHG Group
Prior to joining Kirkland, Arjun worked on the following representative matters:
Advising KMG Chemicals in connection with its $1.6 billion acquisition by Cabot Microelectronics
Advising LyondellBasell in connection with its $2.25 billion acquisition of A. Schulman Inc.
Advising Temasek in connection with the $1.4 billion acquisition of KCG Holdings Inc. by Virtu Financial
Advising American Axle & Manufacturing on its $1.6 billion acquisition of Metaldyne Performance Group
Advising Salesforce on its $2.8 billion acquisition of Demandware
Advising Lanxess on its acquisition of Chemours’ Clean and Disinfect specialties business
